Australia · 
Who invested in Eden Brew?
Eden Brew's investors include Main Sequence Ventures, Possible Ventures and Digitalis Ventures.
Australia · Series A startup
Who invested in Eden Brew
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $15MOct 2023
- Investors
- 3
The rounds
- Oct 2023
Founders and team
From Eden Brew's own website: 1 founder, 14 on the team.
- Anna OxleyChief of Staff
- Darryn HakofChief Commercial Officer
- Malav TrivediChief Strategy and Innovation Officer
- Michael MacridesCFO (Frational)
- Rob BrownChief Scientific Officer
- Alberto RieraPrincipal Protein Scientist
- Alejandra CanteliR&D Operations and Compliance Manager
- Bassam AlkotainiDirector - Bioprocess Technician
- James A. BroadbentPrincipal Analytical Chemist
- Jane FernandezBoard Director
- Paula HurleyFinance Manager (Fractional)
- Sam BeardSenior Protein Scientist & DSP
- Shiva MuthuswamyResearch Associate
- Tyson WatkinsResearch Associate
AdvisersJoel Cherry
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Eden Brew as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Eden Brew
How much has Eden Brew raised?
Eden Brew has raised $15M across 1 round since 2023.
When did Eden Brew last raise?
Eden Brew's most recent round was a Series A of $15M in Oct 2023.
What was Eden Brew's biggest round?
Its most recent round, $15M in Oct 2023, is also its largest on record.
Who backed Eden Brew first?
Eden Brew's first round on record, in Oct 2023, was backed by Main Sequence Ventures, Possible Ventures and Digitalis Ventures.
What stage is Eden Brew at?
Eden Brew's latest named round is a Series A, in Oct 2023.
Where is Eden Brew based?
Eden Brew is based in Australia.
Companies like Eden Brew
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.